News & Updates
Filter by Specialty:
Show Multimedia Only
KEYNOTE-826: Pembrolizumab + chemo +/- bevacizumab improves PFS and OS in East Asians with cervical cancer
24 Jul 2025
byNatalia Reoutova
The addition of pembrolizumab to chemotherapy with or without bevacizumab significantly improves progression-free survival (PFS) and overall survival (OS) in East Asian patients with persistent, recurrent or metastatic cervical cancer, according to an exploratory analysis of the final results from the phase III KEYNOTE-826 trial.
KEYNOTE-826: Pembrolizumab + chemo +/- bevacizumab improves PFS and OS in East Asians with cervical cancer
24 Jul 2025
Predictive model identifies women with COPD in need of palliative care
23 Jul 2025
byStephen Padilla
A newly developed prediction model has demonstrated robust performance in recognizing women with chronic obstructive pulmonary disease (COPD) who might benefit from proactive palliative care. However, external validation is warranted.
